Chunman Zuo

Chunman Zuo


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2021 in Bioinformatics
Verified
Journal Article
Closed access
PDF file
CZChunman Zuo
Chunman Zuo
HDHao Dai
Hao Dai
LCLuonan Chen
Luonan Chen
Joint profiling of single-cell transcriptomics and epigenomics data enables us to characterize cell states and transcriptomics regulatory programs related to cellular heterogeneity. However, the highly different features on sparsity, heterogeneity and dimensionality between multi-omics data have severely hindered its integrative analysis. We proposed deep cross-omics cycle attention (DCCA) model, a computational tool for joint analysis of single-cell multi-omics data, by combining variational autoencoders (VAEs) and attention-transfer. Specifically, we show that DCCA can leverage one omics data to fine-tune the network trained for another omics data, given a dataset of parallel multi-omics data within the same cell. Studies on both simulated and real datasets from various platforms, DCCA demonstrates its superior capability: (i) dissecting cellular heterogeneity; (ii) denoising and aggregating data and (iii) constructing the link between multi-omics data, which is used to infer new transcriptional regulatory relations. In our applications, DCCA was demonstrated to have a superior power to generate missing stages or omics in a biologically meaningful manner, which provides a new way to analyze and also understand complicated biological processes. DCCA source code is available at https://github.com/cmzuo11/DCCA, and has been deposited in archived format at https://doi.org/10.5281/zenodo.4762065. Supplementary data are available at Bioinformatics online.

10 October 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
CZChunman Zuo
Chunman Zuo
YZYijian Zhang
Yijian Zhang
CCChen Cao
Chen Cao
JFJinwang Feng
Jinwang Feng
MJMingqi Jiao
Mingqi Jiao
LCLuonan Chen
Luonan Chen
Spatially resolved transcriptomics (SRT) technology enables us to gain novel insights into tissue architecture and cell development, especially in tumors. However, lacking computational exploitation of biological contexts and multi-view features severely hinders the elucidation of tissue heterogeneity. Here, we propose stMVC, a multi-view graph collaborative-learning model that integrates histology, gene expression, spatial location, and biological contexts in analyzing SRT data by attention. Specifically, stMVC adopting semi-supervised graph attention autoencoder separately learns view-specific representations of histological-similarity-graph or spatial-location-graph, and then simultaneously integrates two-view graphs for robust representations through attention under semi-supervision of biological contexts. stMVC outperforms other tools in detecting tissue structure, inferring trajectory relationships, and denoising on benchmark slices of human cortex. Particularly, stMVC identifies disease-related cell-states and their transition cell-states in breast cancer study, which are further validated by the functional and survival analysis of independent clinical data. Those results demonstrate clinical and prognostic applications from SRT data.

13 June 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
CZChunman Zuo
Chunman Zuo
JXJunjie Xia
Junjie Xia
LCLuonan Chen
Luonan Chen
Spatially resolved transcriptomics (SRT) has enabled precise dissection of tumor-microenvironment (TME) by analyzing its intracellular molecular networks and intercellular cell-cell communication (CCC). However, lacking computational exploration of complicated relations between cells, genes, and histological regions, severely limits the ability to interpret the complex structure of TME. Here, we introduce stKeep, a heterogeneous graph (HG) learning method that integrates multimodality and gene-gene interactions, in unraveling TME from SRT data. stKeep leverages HG to learn both cell-modules and gene-modules by incorporating features of diverse nodes including genes, cells, and histological regions, allows for identifying finer cell-states within TME and cell-state-specific gene-gene relations, respectively. Furthermore, stKeep employs HG to infer CCC for each cell, while ensuring that learned CCC patterns are comparable across different cell-states through contrastive learning. In various cancer samples, stKeep outperforms other tools in dissecting TME such as detecting bi-potent basal populations, neoplastic myoepithelial cells, and metastatic cells distributed within the tumor or leading-edge regions. Notably, stKeep identifies key transcription factors, ligands, and receptors relevant to disease progression, which are further validated by the functional and survival analysis of independent clinical data, thereby highlighting its clinical prognostic and immunotherapy applications.

22 September 2025 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
PGPingting Gao
Pingting Gao
CZChunman Zuo
Chunman Zuo
WYWei Yuan
Wei Yuan
JCJiabin Cai
Jiabin Cai
XCXiaoqiang Chai
Xiaoqiang Chai
PZPinghong Zhou
Pinghong Zhou
Understanding the cellular origins and early evolutionary dynamics that drive the initiation of carcinogenesis is critical to advancing early detection and prevention strategies. By characterizing key molecular, cellular and niche events at the precancerous tipping point of early gastric cancer (EGC), we aimed to develop more precise screening tools and design targeted interventions to prevent malignant transformation at this stage. We utilized our AI models to integrate spatial multimodal data from nine EGC endoscopic submucosal dissection (ESD) samples (covering sequential stages from normal to cancer), construct a spatial-temporal profile of disease progression, and identify a critical tipping point (PMC_P) characterized by an immune-suppressive microenvironment during early cancer development. At this stage, inflammatory pit mucous cells with stemness (PMC_2) interact with fibroblasts via NAMPT $$\longrightarrow$$ ⟶ ITGA5/ITGB1 and with macrophages via AREG $$\longrightarrow$$ ⟶ EGFR/ERBB2 signaling, fostering cancer initiation. We established gastric precancerous cell lines and organoids to demonstrate that NAMPT and AREG promote cellular proliferation in vitro. Furthermore, in the transgenic CEA-SV40 mouse model, targeting AREG and/or NAMPT disrupted key cell interactions, inhibited the JAK-STAT, MAPK, and NFκB pathways, and reduced PD-L1 expression, which was also confirmed by western blot in vitro. These interventions delayed disease progression, reversed the immunosuppressive microenvironment, and prevented malignant transformation. Clinical validation was conducted using endoscopically resected EGC specimens. Our study provides a precise spatiotemporal depiction of EGC development and identifies novel diagnostic markers and therapeutic targets for early intervention.

7 May 2025 in Clinical and Translational Medicine
Verified
Journal Article
Open access
CZChunman Zuo
Chunman Zuo
JZJunchao Zhu
Junchao Zhu
JZJiawei Zou
Jiawei Zou
LCLuonan Chen
Luonan Chen
Analysing the genome, epigenome, transcriptome, proteome, and metabolome within the spatial context of cells has transformed our understanding of tumour spatiotemporal heterogeneity. Advances in spatial multi‐omics technologies now reveal complex molecular interactions shaping cellular behaviour and tissue dynamics. This review highlights key technologies and computational methods that have advanced spatial domain identification and their pseudo‐relations, as well as inference of intra‐ and inter‐cellular molecular networks that drive disease progression. We also discuss strategies to address major challenges, including data sparsity, high‐dimensionality, scalability, and heterogeneity. Furthermore, we outline how spatial multi‐omics enables novel insights into disease mechanisms, advancing precision medicine and informing targeted therapies.Key points: Advancements in spatial multi‐omics facilitate our understanding of tumour spatiotemporal heterogeneity. AI‐driven multimodal models uncover complex molecular interactions that underlie cellular behaviours and tissue dynamics. Combining multi‐omics technologies and AI‐enabled bioinformatics tools helps predict critical disease stages, such as pre‐cancer, advancing precision medicine, and informing targeted therapeutic strategies.

25 January 2024 in Cancer Letters
Verified
Journal Article
Open access
YZYijian Zhang
Yijian Zhang
CZChunman Zuo
Chunman Zuo
YLYang Li
Yang Li
LLLiguo Liu
Liguo Liu
BYBo Yang
Bo Yang
YLYing Bin Liu
Ying Bin Liu
Gallbladder cancer (GBC) is among the most common malignancies of biliary tract system due to its limited treatments. The immunotherapeutic targets for T cells are appealing, however, heterogeneity of T cells hinds its further development. We systematically construct T cell atlas by single-cell RNA sequencing; and utilized the identified gene signatures of high_CNV_T cells to predict molecular subtyping towards personalized therapeutic treatments for GBC. We identified 12 T cell subtypes, where exhausted CD8+ T cells, activated/exhausted CD8+ T cells, and regulatory T cells were predominant in tumors. There appeared to be an inverse relationship between Th17 and Treg populations with Th17 levels significantly reduced, whereas Tregs were concomitantly increased. Furthermore, we first established subtyping criterion to identify three subtypes of GBC based on their pro-tumorigenic microenvironments, e.g., the type 1 group shows more M2 macrophages infiltration, while the type 2 group is infiltrated by highly exhausted CD8+ T cells, B cells and Tregs with suppressive activities. Our study provides valuable insights into T cell heterogeneity and suggests that molecular subtyping based on T cells might provide a potential immunotherapeutic strategy to improve GBC treatment.